Category Archives: Birth Defects

Featured Stories
Soda Consumption Causes Early Puberty & Girls’ Cancer Risk

Soda Consumption Causes Early Puberty and Increases Girls’ Cancer Risk

Drinking just one-and-a-half cans of sugar-sweetened soda a day can bring on early puberty in girls and increase their breast cancer risk.

Read More

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

Death in Those Taking Bactrim with ACE Inhibitors or ARBs

Sudden Death in Those Taking Bactrim Along with ACE Inhibitors or ARBs

Association between sudden death in those given Bactrim while already taking renin-angiotensin system blockers angiotensin receptor blockers (ARBs), heart medications.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Lawsuits filed by alleged victims of DePuy Orthopaedics’ recalled ASR hip replacement devices continue to pile up in the multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio. Most recently, a woman from Pryor, Oklahoma, filed suit alleging complications caused by a DePuy ASR hip implant ...

Read More

Exposure to 9/11 Toxic Cloud Linked to Low Birth Weight Babies

Fifteen years after the collapse of the World Trade Center towers in the September 11, 2001 terrorist attack, researchers are still learning the impact of the attacks on people’s health. When the twin towers fell, a cloud of toxic dust … Continue reading

Posted in Birth Defects, Health Concerns, Toxic Substances |

New Jersey Mother Blames Zofran for Daughter’s Birth Defects

A woman alleges her daughter, born in 2007, is a victim of her having taken Zofran during her first trimester of pregnancy. The anti-nausea drug is a treatment for chemotherapy patients, radiation patients, and patients’ recovering from the effects of … Continue reading

Posted in Birth Defects, Health Concerns, Legal News, Pharmaceuticals |

Zofran Birth Defect Lawsuit Update: “Sequence Discovery” Issue

Zofran Birth Defect Case Update: “Sequence Discovery” Issue

Plaintiffs in more than 200 birth defect lawsuits have raised concerns over the pharmaceutical company GlaxoSmithKline’s (GSK) new proposal for Sequenced Discovery. Parents say the company neglected to warn patients and health experts of its anti-nausea drug Zofran’s alleged potential … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals | Tagged , , , , , |

Using Short Form Complaint, New Zofran Lawsuit Filed in Massachusetts Court

There will be a new way to file Zofran lawsuits that claim the pharmaceutical giant GlaxoSmithKline’s anti-nausea drug Zofran can cause birth defects. More than 260 families claim that GlaxoSmithKline (GSK) failed to warn them of Zofran’s alleged risks, in … Continue reading

Posted in Birth Defects, Health Concerns, Legal News, Pharmaceuticals |

Zofran Birth Defects Litigation Moves Forward

In the federal multidistrict litigation (MDL) presently underway in the U.S. District Court, District of Massachusetts, more than 260 Zofran birth defect lawsuits continue to move forward. The parties involved have jointly submitted proposed Master Long Form and Short Form … Continue reading

Posted in Birth Defects, Health Concerns, Legal News, Pharmaceuticals |

Study Shows Lyrica Linked to Major Birth Defects

New research has linked the medication Lyrica with birth defects in the babies of pregnant woman who take the drug. Lyrica (pregabalin) is prescribed to treat seizures, neuropathic pain, fibromyalgia, anxiety disorders, psychiatric conditions, and restless leg syndrome. But there … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals |

Risk of Major Birth Defects when Lyrica is taken during Pregnancy

Lyrica (pregabalin) is used to treat diabetic nerve pain, fibromyalgia, epilepsy, post-herpetic neuraligia caused by shingles and spinal cord injury. It is also prescribed “off label”, meaning it is approved by the U.S. Food and Drug Administraton (FDA), but specified … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals |

Scientists Call for Fresh Look at Dangers of Glyphosate Herbicides

A group of health scientists worried about the explosive growth of agricultural chemicals’ use worldwide is pressing U.S. and European health officials to examine the health impacts of glyphosate herbicides. A report published on February 17, 2016 in Environmental Health, … Continue reading

Posted in Birth Defects, Health Concerns, Toxic Substances |

Judge Denies GlaxoSmithKline Motion to Dismiss Birth Defect Claims in Zofran Litigation

On January 22, 2016, a federal judge in Massachusetts denied GlaxoSmithKline’s motion to dismiss all claims in multidistrict litigation alleging that the drug company’s off-label promotion of its anti-nausea drug Zofran (ondansetron) for morning sickness led to birth defects. U.S. District … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals |

Federal Judge Denies Motion to Dismiss Claims in Zofran Birth Defect Cases

zofran-baby

A federal judge in Massachusetts has denied a motion by drug maker GlaxoSmithKline to dismiss cases alleging that the drug Zofran (ondansetron) caused birth defects on the grounds that federal law preempts state failure-to-warn claims. Federal law is the “supreme” … Continue reading

Posted in Birth Defects, Defective Products, Health Concerns, Legal News, Pharmaceuticals | Tagged , , , , |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.